[
  {
    "title": "九洲药业(603456.SH)12月未实施回购",
    "href": "http://stock.jrj.com.cn/2023/01/03162837255417.shtml",
    "datetime": "2023-01-03 16:28:49",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)截止11月底已累计回购125.73万股",
    "href": "http://stock.jrj.com.cn/2022/12/01161537181519.shtml",
    "datetime": "2022-12-01 16:15:49",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：不超7000万股定增计划获批",
    "href": "http://stock.jrj.com.cn/2022/11/29161537174506.shtml",
    "datetime": "2022-11-29 16:15:24",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：54.57万股限制性股票将解锁上市流通",
    "href": "http://stock.jrj.com.cn/2022/11/21174637154820.shtml",
    "datetime": "2022-11-21 17:46:02",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：非公开发行股票申请获证监会审核通过",
    "href": "http://stock.jrj.com.cn/2022/11/14170637137379.shtml",
    "datetime": "2022-11-14 17:06:54",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)截止10月底已累计回购89.9万股",
    "href": "http://stock.jrj.com.cn/2022/11/01161937103349.shtml",
    "datetime": "2022-11-01 16:19:44",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：四维医药药品生产许可证变更 涉及分类码及受托情况",
    "href": "http://stock.jrj.com.cn/2022/10/31161837099868.shtml",
    "datetime": "2022-10-31 16:18:28",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：控股子公司九洲生物获批成为磷酸西格列汀片上市许可持有人",
    "href": "http://stock.jrj.com.cn/2022/10/31161537099875.shtml",
    "datetime": "2022-10-31 16:15:41",
    "code": "603456"
  },
  {
    "title": "A股异动 | 九洲药业(603456.SH)涨7.4% 绩后获券商看好",
    "href": "http://stock.jrj.com.cn/2022/10/26100837084644.shtml",
    "datetime": "2022-10-26 10:08:59",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：第三季度净利增38.77%至2.75亿元",
    "href": "http://stock.jrj.com.cn/2022/10/25180537082419.shtml",
    "datetime": "2022-10-25 18:05:39",
    "code": "603456"
  },
  {
    "title": "九洲药业更正2022年前三季度扣非后净利润：同比增加 70%到75%",
    "href": "http://stock.jrj.com.cn/2022/10/17103237059495.shtml",
    "datetime": "2022-10-17 10:32:13",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：预计前三季度净利同比增加55%到60%",
    "href": "http://stock.jrj.com.cn/2022/10/16170037058385.shtml",
    "datetime": "2022-10-16 17:00:17",
    "code": "603456"
  },
  {
    "title": "A股异动 | 九洲药业(603456.SH)涨5% 拟收购山德士(中国)所属中山制剂工厂",
    "href": "http://stock.jrj.com.cn/2022/09/29102037030087.shtml",
    "datetime": "2022-09-29 10:20:22",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：拟收购山德士(中国)所属中山制剂工厂100%股权并对其增资",
    "href": "http://stock.jrj.com.cn/2022/09/27222237026292.shtml",
    "datetime": "2022-09-27 22:22:24",
    "code": "603456"
  },
  {
    "title": "A股异动 | 九洲药业连续2日反弹 昨日低位回购12万股",
    "href": "http://stock.jrj.com.cn/2022/09/15095336996214.shtml",
    "datetime": "2022-09-15 09:53:25",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：9月14日首次回购12万股",
    "href": "http://stock.jrj.com.cn/2022/09/14162036994221.shtml",
    "datetime": "2022-09-14 16:20:13",
    "code": "603456"
  },
  {
    "title": "【龙虎榜】九洲药业9月13日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/09/13180536991819.shtml",
    "datetime": "2022-09-13 18:05:55",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：非公开发行A股股票申请获证监会受理",
    "href": "http://stock.jrj.com.cn/2022/09/09162436986560.shtml",
    "datetime": "2022-09-09 16:24:17",
    "code": "603456"
  },
  {
    "title": "九洲药业：拟斥资0.5亿元-1.0亿元回购公司股份",
    "href": "http://stock.jrj.com.cn/2022/09/01095836961613.shtml",
    "datetime": "2022-09-01 09:58:53",
    "code": "603456"
  },
  {
    "title": "九洲药业等拟回购股份",
    "href": "http://stock.jrj.com.cn/hotstock/2022/09/01074736961225.shtml",
    "datetime": "2022-09-01 07:47:04",
    "code": "603456"
  },
  {
    "title": "九洲药业：拟以5000万元-1亿元回购股份 回购价格不超过60元/股",
    "href": "http://stock.jrj.com.cn/2022/08/31163236958271.shtml",
    "datetime": "2022-08-31 16:32:49",
    "code": "603456"
  },
  {
    "title": "九洲药业：拟斥0.5亿元-1.0亿元回购公司股份",
    "href": "http://stock.jrj.com.cn/2022/08/31160336958141.shtml",
    "datetime": "2022-08-31 16:03:03",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：拟斥0.5亿元-1.0亿元回购公司股份",
    "href": "http://stock.jrj.com.cn/2022/08/31155736958120.shtml",
    "datetime": "2022-08-31 15:57:34",
    "code": "603456"
  },
  {
    "title": "九洲药业：2022年半年实现营收29.54亿元，同比增长58.15%",
    "href": "http://stock.jrj.com.cn/2022/08/05133436873351.shtml",
    "datetime": "2022-08-05 13:34:09",
    "code": "603456"
  },
  {
    "title": "九洲药业2022年上半年净利4.68亿同比增长70.31% CDMO业务增加",
    "href": "http://stock.jrj.com.cn/2022/08/04185136871104.shtml",
    "datetime": "2022-08-04 18:51:10",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：46.44万股限制性股票将解锁上市流通",
    "href": "http://stock.jrj.com.cn/2022/08/04172236870692.shtml",
    "datetime": "2022-08-04 17:22:36",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：拟定增募资不超25亿元 用于瑞博(台州)制药创新药CDMO生产基地建设项目(一期工程)等",
    "href": "http://stock.jrj.com.cn/2022/08/04164836870511.shtml",
    "datetime": "2022-08-04 16:48:43",
    "code": "603456"
  },
  {
    "title": "九洲药业：拟定增募资不超过25亿元",
    "href": "http://stock.jrj.com.cn/2022/08/04164636870454.shtml",
    "datetime": "2022-08-04 16:46:58",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：上半年净利润增70.31%至4.68亿元",
    "href": "http://stock.jrj.com.cn/2022/08/04164436870516.shtml",
    "datetime": "2022-08-04 16:44:38",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：预计上半年归母净利增69.69%至4.66亿元",
    "href": "http://stock.jrj.com.cn/2022/07/21194936833109.shtml",
    "datetime": "2022-07-21 19:49:19",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：康川济医药获得药品生产许可证",
    "href": "http://stock.jrj.com.cn/2022/07/13201436808705.shtml",
    "datetime": "2022-07-13 20:14:09",
    "code": "603456"
  },
  {
    "title": "九洲药业2022年上半年预计净利4.53亿-4.81亿同比增加65%-75% 产品交付能力提升",
    "href": "http://stock.jrj.com.cn/2022/07/12051036801129.shtml",
    "datetime": "2022-07-12 05:10:57",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：控股股东及其一致行动人持股从52.28%减至47.28%",
    "href": "http://stock.jrj.com.cn/2022/06/24162436756827.shtml",
    "datetime": "2022-06-24 16:24:45",
    "code": "603456"
  },
  {
    "title": "九洲药业一季度营利双增，归母净利同比增长超1倍",
    "href": "http://stock.jrj.com.cn/2022/04/20142136408865.shtml",
    "datetime": "2022-04-20 14:21:27",
    "code": "603456"
  },
  {
    "title": "九洲药业2021年净利6.34亿同比增长66.56% 董事长花莉蓉薪酬195.08万",
    "href": "http://stock.jrj.com.cn/2022/04/20051136404984.shtml",
    "datetime": "2022-04-20 05:11:47",
    "code": "603456"
  },
  {
    "title": "九洲药业2022年第一季度净利2.08亿同比增长120.13% CDMO业务增加",
    "href": "http://stock.jrj.com.cn/2022/04/19215036402452.shtml",
    "datetime": "2022-04-19 21:50:48",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：2021年净利增66.56%至6.34亿元 拟10派2.5元",
    "href": "http://stock.jrj.com.cn/2022/04/19180736400341.shtml",
    "datetime": "2022-04-19 18:07:17",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：一季度净利增120.13%至2.08亿元",
    "href": "http://stock.jrj.com.cn/2022/04/19180436400345.shtml",
    "datetime": "2022-04-19 18:04:54",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：MPP授予的奈玛特韦的仿制药原料药非独家许可",
    "href": "http://stock.jrj.com.cn/2022/03/20154634851992.shtml",
    "datetime": "2022-03-20 15:46:40",
    "code": "603456"
  },
  {
    "title": "九洲药业：MPP授予的奈玛特韦仿制药原料药非独家许可",
    "href": "http://stock.jrj.com.cn/2022/03/20154334851985.shtml",
    "datetime": "2022-03-20 15:43:44",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：拟通过增资扩股方式向九洲生物引入员工持股平台",
    "href": "http://stock.jrj.com.cn/2022/03/18171334845741.shtml",
    "datetime": "2022-03-18 17:13:19",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：向286名激励对象授予178.6万股限制性股票",
    "href": "http://stock.jrj.com.cn/2022/03/18171034845719.shtml",
    "datetime": "2022-03-18 17:10:13",
    "code": "603456"
  },
  {
    "title": "【龙虎榜】九洲药业3月17日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/17180334840096.shtml",
    "datetime": "2022-03-17 18:03:50",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：拟推2022年限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2022/03/02165334512534.shtml",
    "datetime": "2022-03-02 16:53:25",
    "code": "603456"
  },
  {
    "title": "九洲药业2021年预计净利6.09亿-6.85亿同比增加60%-80% CDMO业务持续增长",
    "href": "http://stock.jrj.com.cn/2022/01/18191234170840.shtml",
    "datetime": "2022-01-18 19:12:08",
    "code": "603456"
  },
  {
    "title": "九洲药业：CDMO业务持续增长 2021年净利同比预增60%到80%",
    "href": "http://stock.jrj.com.cn/2022/01/18173834170374.shtml",
    "datetime": "2022-01-18 17:38:41",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)2021年度净利润预增60%-80%",
    "href": "http://stock.jrj.com.cn/2022/01/18161334169777.shtml",
    "datetime": "2022-01-18 16:13:15",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：拟使用不超5.2亿元闲置募集资金临时补充流动资金",
    "href": "http://stock.jrj.com.cn/2022/01/12163234150107.shtml",
    "datetime": "2022-01-12 16:32:06",
    "code": "603456"
  },
  {
    "title": "收购+增资 九洲药业(603456.SH)斥1.2亿元获康川济医药51%股权",
    "href": "http://stock.jrj.com.cn/2022/01/03155834109220.shtml",
    "datetime": "2022-01-03 15:58:32",
    "code": "603456"
  },
  {
    "title": "【龙虎榜】九洲药业12月15日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/12/15180634020321.shtml",
    "datetime": "2021-12-15 18:06:52",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：控股股东一致行动人以大宗交易累计减持1144万股",
    "href": "http://stock.jrj.com.cn/2021/12/06155633973790.shtml",
    "datetime": "2021-12-06 15:56:01",
    "code": "603456"
  },
  {
    "title": "A股异动 | 收购泰华杭州消息持续发酵，九洲药业(603456.SH)续涨5.7%创新高",
    "href": "http://stock.jrj.com.cn/2021/11/26133833923194.shtml",
    "datetime": "2021-11-26 13:38:11",
    "code": "603456"
  },
  {
    "title": "九洲药业加速转型CDMO收入贡献近半 拟2.17亿收购原料药工厂扩大优势",
    "href": "http://stock.jrj.com.cn/2021/11/25074433917257.shtml",
    "datetime": "2021-11-25 07:44:42",
    "code": "603456"
  },
  {
    "title": "A股异动 | 九洲药业(603456.SH)涨超6% 拟收购泰华杭州全部股份",
    "href": "http://stock.jrj.com.cn/2021/11/24095233913215.shtml",
    "datetime": "2021-11-24 09:52:32",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：拟以3400万美元收购泰华杭州100%的股权",
    "href": "http://stock.jrj.com.cn/2021/11/23170333909864.shtml",
    "datetime": "2021-11-23 17:03:15",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)绩后跳涨超6% Q3业绩超预期",
    "href": "http://stock.jrj.com.cn/2021/10/29115633776202.shtml",
    "datetime": "2021-10-29 11:56:13",
    "code": "603456"
  },
  {
    "title": "九洲药业：第三季度净利1.98亿元 同比增80.39%",
    "href": "http://stock.jrj.com.cn/2021/10/28214833772666.shtml",
    "datetime": "2021-10-28 21:48:48",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：第三季度净利增80.39%至1.98亿元",
    "href": "http://stock.jrj.com.cn/2021/10/28192533771412.shtml",
    "datetime": "2021-10-28 19:25:47",
    "code": "603456"
  },
  {
    "title": "九洲药业闪崩跌停 或受罗氏新冠口服药失败影响",
    "href": "http://stock.jrj.com.cn/2021/10/20135633721222.shtml",
    "datetime": "2021-10-20 13:56:12",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：瑞博苏州沙库巴曲缬沙坦钠原料药及中间体通过日本GMP符合性检查",
    "href": "http://stock.jrj.com.cn/2021/10/11160733673164.shtml",
    "datetime": "2021-10-11 16:07:11",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：子公司的奥卡西平片、卡马西平胶囊获得药品生产许可证",
    "href": "http://stock.jrj.com.cn/2021/09/03161633380144.shtml",
    "datetime": "2021-09-03 16:16:27",
    "code": "603456"
  },
  {
    "title": "九洲药业净利2.75亿同比翻倍 手握超500个CDMO项目两年半增67%",
    "href": "http://stock.jrj.com.cn/2021/08/18074133271539.shtml",
    "datetime": "2021-08-18 07:41:09",
    "code": "603456"
  },
  {
    "title": "九洲药业2021年半年度净利2.75亿元 同比净利增加112.32%",
    "href": "http://stock.jrj.com.cn/2021/08/16180733261561.shtml",
    "datetime": "2021-08-16 18:07:00",
    "code": "603456"
  },
  {
    "title": "九洲药业半年报：上半年净利2.75亿元 同比增长112%",
    "href": "http://stock.jrj.com.cn/2021/08/16163933260808.shtml",
    "datetime": "2021-08-16 16:39:17",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：拟出资5000万元参投苏州泰福怀谨创业投资合伙企业",
    "href": "http://stock.jrj.com.cn/2021/08/16163233260771.shtml",
    "datetime": "2021-08-16 16:32:01",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)上半年净利升112.32%至2.75亿元",
    "href": "http://stock.jrj.com.cn/2021/08/16163033260753.shtml",
    "datetime": "2021-08-16 16:30:01",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：2617.12万股限售股将于8月9日上市流通",
    "href": "http://stock.jrj.com.cn/2021/08/02173433189782.shtml",
    "datetime": "2021-08-02 17:34:42",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：子公司以4373万元竞得杭州钱塘新区一地块使用权",
    "href": "http://stock.jrj.com.cn/2021/07/30160133175524.shtml",
    "datetime": "2021-07-30 16:01:27",
    "code": "603456"
  },
  {
    "title": "九洲药业：上半年净利润预计同比增长105%-120%",
    "href": "http://stock.jrj.com.cn/2021/07/20070733122204.shtml",
    "datetime": "2021-07-20 07:07:00",
    "code": "603456"
  },
  {
    "title": "九洲药业2021年上半年预计净利2.65亿-2.85亿增长105%-120% API业务产能稳步攀升",
    "href": "http://stock.jrj.com.cn/2021/07/19193133120408.shtml",
    "datetime": "2021-07-19 19:31:55",
    "code": "603456"
  },
  {
    "title": "九洲药业：2021年半年度业绩同比预增105%到120%",
    "href": "http://stock.jrj.com.cn/2021/07/19165533119902.shtml",
    "datetime": "2021-07-19 16:55:14",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：上半年预盈2.65亿元-2.85亿元 同比增加105.00%-120.00%",
    "href": "http://stock.jrj.com.cn/2021/07/19161233119304.shtml",
    "datetime": "2021-07-19 16:12:43",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：2020年度权益分派10派2元 股权登记日7月9日",
    "href": "http://stock.jrj.com.cn/2021/07/05220333049338.shtml",
    "datetime": "2021-07-05 22:03:15",
    "code": "603456"
  },
  {
    "title": "机构反复助攻九洲药业 两游资大哥出逃小康股份",
    "href": "http://stock.jrj.com.cn/2021/06/22082732974089.shtml",
    "datetime": "2021-06-22 08:27:56",
    "code": "603456"
  },
  {
    "title": "【龙虎榜】九洲药业6月21日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/06/21180732970574.shtml",
    "datetime": "2021-06-21 18:07:11",
    "code": "603456"
  },
  {
    "title": "九洲药业：向公司2021年限制性股票激励计划激励对象授予限制性股票",
    "href": "http://stock.jrj.com.cn/2021/06/03171532869993.shtml",
    "datetime": "2021-06-03 17:15:08",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：向176位激励对象授予限制性股票共计128.70万股",
    "href": "http://stock.jrj.com.cn/2021/06/03165532869683.shtml",
    "datetime": "2021-06-03 16:55:00",
    "code": "603456"
  },
  {
    "title": "【龙虎榜】九洲药业5月28日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/05/28180732836181.shtml",
    "datetime": "2021-05-28 18:07:00",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)拟推2021年限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2021/05/18184832777352.shtml",
    "datetime": "2021-05-18 18:48:32",
    "code": "603456"
  },
  {
    "title": "九洲药业2020年净利增长60.05% 董事长花莉蓉薪酬128.08万",
    "href": "http://stock.jrj.com.cn/2021/04/28221432474645.shtml",
    "datetime": "2021-04-28 22:14:21",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)2020年度净利润升60.05%至3.81亿元 拟10派2元",
    "href": "http://stock.jrj.com.cn/2021/04/27192632464922.shtml",
    "datetime": "2021-04-27 19:26:49",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)一季度净利润升190.92%至9440.42万元",
    "href": "http://stock.jrj.com.cn/2021/04/27192132464906.shtml",
    "datetime": "2021-04-27 19:21:01",
    "code": "603456"
  },
  {
    "title": "九洲药业原监事许加君收警示函 配偶短线交易公司股票",
    "href": "http://stock.jrj.com.cn/2021/03/16163932145455.shtml",
    "datetime": "2021-03-16 16:39:00",
    "code": "603456"
  },
  {
    "title": "九洲药业原监事许加君遭通报批评 配偶短线交易",
    "href": "http://stock.jrj.com.cn/2021/03/09181332098855.shtml",
    "datetime": "2021-03-09 18:13:00",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：控股股东及一致行动人持股比例减少至49.56%",
    "href": "http://stock.jrj.com.cn/2021/02/09175031878284.shtml",
    "datetime": "2021-02-09 17:50:57",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)拟以不超5.5亿元闲置募集资金临时补充流动资金",
    "href": "http://stock.jrj.com.cn/2021/02/08220031872764.shtml",
    "datetime": "2021-02-08 22:00:41",
    "code": "603456"
  },
  {
    "title": "九洲药业2020年预计净利3.69亿-4.04亿增加55%-70% CDMO业务增长",
    "href": "http://stock.jrj.com.cn/2021/01/27212931793414.shtml",
    "datetime": "2021-01-27 21:29:46",
    "code": "603456"
  },
  {
    "title": "九洲药业：为进一步扩大CDMO产业规模 拟1亿元新设瑞博（台州）制药",
    "href": "http://stock.jrj.com.cn/2021/01/26175831779323.shtml",
    "datetime": "2021-01-26 17:58:55",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：公司通过高新技术企业重新认定",
    "href": "http://stock.jrj.com.cn/2021/01/18161831715460.shtml",
    "datetime": "2021-01-18 16:18:29",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)定增申请获中国证监会核准",
    "href": "http://stock.jrj.com.cn/2021/01/14173131692557.shtml",
    "datetime": "2021-01-14 17:31:44",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：公司1.13亿元竞得一处土地使用权",
    "href": "http://stock.jrj.com.cn/2020/12/30163131605135.shtml",
    "datetime": "2020-12-30 16:31:49",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：非公开发行股票申请获审核通过",
    "href": "http://stock.jrj.com.cn/2020/12/28173231587026.shtml",
    "datetime": "2020-12-28 17:32:52",
    "code": "603456"
  },
  {
    "title": "[九洲药业]合作共赢,瑞博制药助力华领医药创新药全球领跑",
    "href": "http://stock.jrj.com.cn/2020/12/18000031667890.shtml",
    "datetime": "2020-12-18 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]九洲药业入选上证380指数",
    "href": "http://stock.jrj.com.cn/2020/12/04000031410135.shtml",
    "datetime": "2020-12-04 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]“赶考”路上,瑞博(苏州)交出满意“成绩单”",
    "href": "http://stock.jrj.com.cn/2020/12/04000031408302.shtml",
    "datetime": "2020-12-04 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业拟投资设立全资子公司 注册资本5000万元",
    "href": "http://stock.jrj.com.cn/2020/11/27190831362130.shtml",
    "datetime": "2020-11-27 19:08:45",
    "code": "603456"
  },
  {
    "title": "九洲药业：为进一步拓展公司医药产业布局 拟在杭州设立全资子公司",
    "href": "http://stock.jrj.com.cn/2020/11/27164031361103.shtml",
    "datetime": "2020-11-27 16:40:13",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)：子公司增加3.5亿元的银行授信额度提供资产抵押",
    "href": "http://stock.jrj.com.cn/2020/11/27160431360955.shtml",
    "datetime": "2020-11-27 16:04:54",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)拟5000万元设立杭州九洲医药股权投资有限公司",
    "href": "http://stock.jrj.com.cn/2020/11/27160331360957.shtml",
    "datetime": "2020-11-27 16:03:17",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)拟向九洲生物增资5000万元",
    "href": "http://stock.jrj.com.cn/2020/11/27160231360959.shtml",
    "datetime": "2020-11-27 16:02:20",
    "code": "603456"
  },
  {
    "title": "[九洲药业]安全,没有“破个例”",
    "href": "http://stock.jrj.com.cn/2020/11/09000031322648.shtml",
    "datetime": "2020-11-09 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业拟16亿元投建两项目",
    "href": "http://stock.jrj.com.cn/2020/11/05214831223803.shtml",
    "datetime": "2020-11-05 21:48:00",
    "code": "603456"
  },
  {
    "title": "首批国家组织的冠脉支架集采拟中选结果出炉 九洲药业拟16亿元建设CDMO及制剂基地项目 | 医资日报",
    "href": "http://stock.jrj.com.cn/2020/11/05180931222664.shtml",
    "datetime": "2020-11-05 18:09:27",
    "code": "603456"
  },
  {
    "title": "九洲药业(603456.SH)拟投资16亿元建设CDMO及制剂基地项目",
    "href": "http://stock.jrj.com.cn/2020/11/05170631222359.shtml",
    "datetime": "2020-11-05 17:06:13",
    "code": "603456"
  },
  {
    "title": "[九洲药业]第二届创新药物研究(暨抗病毒药物开发)高峰论坛在杭州举行",
    "href": "http://stock.jrj.com.cn/2020/11/02000031322644.shtml",
    "datetime": "2020-11-02 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：2020年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/10/22001031103703.shtml",
    "datetime": "2020-10-22 00:10:25",
    "code": "603456"
  },
  {
    "title": "九洲药业前三季度净利2.39亿增长76.42% CDMO业务增长",
    "href": "http://stock.jrj.com.cn/2020/10/21182131101803.shtml",
    "datetime": "2020-10-21 18:21:41",
    "code": "603456"
  },
  {
    "title": "[九洲药业]九洲药业荣登“2020中国化学制药行业优秀企业和优秀产品品牌”榜",
    "href": "http://stock.jrj.com.cn/2020/10/15000031322643.shtml",
    "datetime": "2020-10-15 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]省药监局副局长邵元昌一行来九洲药业开展“三服务”活动",
    "href": "http://stock.jrj.com.cn/2020/09/18000031032256.shtml",
    "datetime": "2020-09-18 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：2020年第一次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2020/09/11135030729269.shtml",
    "datetime": "2020-09-11 13:50:02",
    "code": "603456"
  },
  {
    "title": "九洲药业：第六届董事会第三十次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/09/11135030729268.shtml",
    "datetime": "2020-09-11 13:50:01",
    "code": "603456"
  },
  {
    "title": "九洲药业拟定增募资不超10亿元",
    "href": "http://stock.jrj.com.cn/2020/09/07215530695614.shtml",
    "datetime": "2020-09-07 21:55:54",
    "code": "603456"
  },
  {
    "title": "[九洲药业]九洲药业:携手上海医药,开创合作新模式,构建原料药与制剂一体化格局",
    "href": "http://stock.jrj.com.cn/2020/08/28000031032253.shtml",
    "datetime": "2020-08-28 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]瑞博制药牵手和黄医药达成新阶段新时期战略合作关系",
    "href": "http://stock.jrj.com.cn/2020/07/15000030431174.shtml",
    "datetime": "2020-07-15 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]钱塘新区党工委副书记、常务副主任施华淼来九洲药业考察调研",
    "href": "http://stock.jrj.com.cn/2020/07/13000030251254.shtml",
    "datetime": "2020-07-13 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]省政协副主席蔡秀军走访调研九洲药业",
    "href": "http://stock.jrj.com.cn/2020/07/10000030251253.shtml",
    "datetime": "2020-07-10 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]省经信厅副厅长杜华红一行走访调研瑞博制药",
    "href": "http://stock.jrj.com.cn/2020/07/10000030251251.shtml",
    "datetime": "2020-07-10 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]台州市委常委、军分区政委周厚江来九洲药业走访调研",
    "href": "http://stock.jrj.com.cn/2020/06/08000030251247.shtml",
    "datetime": "2020-06-08 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：2019年年度股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2020/05/12232029653907.shtml",
    "datetime": "2020-05-12 23:20:04",
    "code": "603456"
  },
  {
    "title": "九洲药业2020年第一季度净利3245.03万下滑25.28% 政府补助减少所致",
    "href": "http://stock.jrj.com.cn/2020/05/03133629495976.shtml",
    "datetime": "2020-05-03 13:36:29",
    "code": "603456"
  },
  {
    "title": "[九洲药业]瑞博(苏州)制药入选苏州市首批潜力地标培育企业",
    "href": "http://stock.jrj.com.cn/2020/04/27000029393502.shtml",
    "datetime": "2020-04-27 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]浙江首次发布创造力企业百强名单,九洲药业榜上有名",
    "href": "http://stock.jrj.com.cn/2020/04/24000029393503.shtml",
    "datetime": "2020-04-24 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：第六届董事会第二十三次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/04/08231029240210.shtml",
    "datetime": "2020-04-08 23:10:30",
    "code": "603456"
  },
  {
    "title": "九洲药业：关于召开2019年年度股东大会的通知",
    "href": "http://stock.jrj.com.cn/2020/04/08231029240209.shtml",
    "datetime": "2020-04-08 23:10:29",
    "code": "603456"
  },
  {
    "title": "九洲药业：2019年年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/04/08231029240208.shtml",
    "datetime": "2020-04-08 23:10:28",
    "code": "603456"
  },
  {
    "title": "九洲药业：2019年净利同比增51% 拟10派2元",
    "href": "http://stock.jrj.com.cn/2020/04/08212129239544.shtml",
    "datetime": "2020-04-08 21:21:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]浙江中贝九洲集团有限公司再获2019年台州纳税百强企业",
    "href": "http://stock.jrj.com.cn/2020/03/12000029032957.shtml",
    "datetime": "2020-03-12 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]省市场监管局副巡视员陈锦寿一行来九洲药业走访调研",
    "href": "http://stock.jrj.com.cn/2020/02/27000029032958.shtml",
    "datetime": "2020-02-27 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：子公司目前为停产状态 或会对公司业绩产生一定影响",
    "href": "http://stock.jrj.com.cn/2020/02/25172128891016.shtml",
    "datetime": "2020-02-25 17:21:58",
    "code": "603456"
  },
  {
    "title": "[九洲药业]省科技厅副厅长曹新安一行来九洲药业开展“三服务“活动",
    "href": "http://stock.jrj.com.cn/2020/02/25000029032956.shtml",
    "datetime": "2020-02-25 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]九洲药业护“驾”,员工平安回“家”—九洲药业首批“返岗包车”大巴车发车",
    "href": "http://stock.jrj.com.cn/2020/02/20000028873099.shtml",
    "datetime": "2020-02-20 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：与吉利德未就在研药物瑞德西韦开展实质性合作",
    "href": "http://stock.jrj.com.cn/2020/02/05185428777648.shtml",
    "datetime": "2020-02-05 18:54:26",
    "code": "603456"
  },
  {
    "title": "九洲药业：与吉利德公司未就在研药物瑞德西韦开展实质性合作",
    "href": "http://stock.jrj.com.cn/2020/02/05183228777254.shtml",
    "datetime": "2020-02-05 18:32:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：未就新型冠状病毒肺炎在研药物Remdesivir开展实质性合作",
    "href": "http://stock.jrj.com.cn/2020/02/05175528777105.shtml",
    "datetime": "2020-02-05 17:55:41",
    "code": "603456"
  },
  {
    "title": "吉利德概念大涨 九洲药业、博腾股份、永太科技涨停",
    "href": "http://stock.jrj.com.cn/2020/02/05094128774031.shtml",
    "datetime": "2020-02-05 09:41:20",
    "code": "603456"
  },
  {
    "title": "九洲药业：吉利德的产品销售收入占公司营收不超过2%",
    "href": "http://stock.jrj.com.cn/2020/02/04210928768708.shtml",
    "datetime": "2020-02-04 21:09:52",
    "code": "603456"
  },
  {
    "title": "九洲药业：近两年吉利德公司的产品销售收入占比不超过2%",
    "href": "http://stock.jrj.com.cn/2020/02/04210228768678.shtml",
    "datetime": "2020-02-04 21:02:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：吉利德是公司战略合作伙伴",
    "href": "http://stock.jrj.com.cn/2020/02/04104528764801.shtml",
    "datetime": "2020-02-04 10:45:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：公司已为吉利德提供多个品种的CDMO服",
    "href": "http://stock.jrj.com.cn/2020/02/04103928764704.shtml",
    "datetime": "2020-02-04 10:39:56",
    "code": "603456"
  },
  {
    "title": "[九洲药业]众志成城,抗击疫情,九洲药业在行动!",
    "href": "http://stock.jrj.com.cn/2020/02/02000028873100.shtml",
    "datetime": "2020-02-02 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]台州市委书记李跃旗来九洲药业检查节日期间安全生产工作",
    "href": "http://stock.jrj.com.cn/2020/01/23000028873101.shtml",
    "datetime": "2020-01-23 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：2019年年度业绩报告预告(修正公告)",
    "href": "http://stock.jrj.com.cn/2020/01/22100028718932.shtml",
    "datetime": "2020-01-22 10:00:41",
    "code": "603456"
  },
  {
    "title": "九洲药业：2019年年度业绩预增公告",
    "href": "http://stock.jrj.com.cn/2020/01/22002028715859.shtml",
    "datetime": "2020-01-22 00:20:13",
    "code": "603456"
  },
  {
    "title": "九洲药业2019年度预计实现净利2.44亿元至2.83亿元 同比增加55%到80%",
    "href": "http://stock.jrj.com.cn/2020/01/21171928713985.shtml",
    "datetime": "2020-01-21 17:19:59",
    "code": "603456"
  },
  {
    "title": "九洲药业：2019年度净利同比预增55%-80%",
    "href": "http://stock.jrj.com.cn/2020/01/21161828713655.shtml",
    "datetime": "2020-01-21 16:18:34",
    "code": "603456"
  },
  {
    "title": "九洲药业：2019年净利预增55%-80%",
    "href": "http://stock.jrj.com.cn/2020/01/21160228713593.shtml",
    "datetime": "2020-01-21 16:02:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]携手合作廿余载战略结盟结新果,九洲药业、瑞博制药荣获诺华集团“NTO Valued Partner 2019”",
    "href": "http://stock.jrj.com.cn/2020/01/09000028676737.shtml",
    "datetime": "2020-01-09 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]通过CNAS认证,九洲药业工艺安全实验室跻身“国家认可实验室”行列",
    "href": "http://stock.jrj.com.cn/2020/01/02000028676734.shtml",
    "datetime": "2020-01-02 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]中贝九洲集团工会被省总工会命名为浙江省“农民工文化家园”称号",
    "href": "http://stock.jrj.com.cn/2019/12/30000028676736.shtml",
    "datetime": "2019-12-30 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：子公司CMO平台建设项目获得政府补助6000万元",
    "href": "http://stock.jrj.com.cn/2019/12/26224928592923.shtml",
    "datetime": "2019-12-26 22:49:41",
    "code": "603456"
  },
  {
    "title": "九洲药业：子公司获得政府补助6000万元",
    "href": "http://stock.jrj.com.cn/2019/12/26160028590799.shtml",
    "datetime": "2019-12-26 16:00:54",
    "code": "603456"
  },
  {
    "title": "九洲药业：预计公司特色原料药价格未来会上浮",
    "href": "http://stock.jrj.com.cn/2019/12/26104328589244.shtml",
    "datetime": "2019-12-26 10:43:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：苏州诺华制药科技有限公司100%股权交割完成",
    "href": "http://stock.jrj.com.cn/2019/12/20231128564970.shtml",
    "datetime": "2019-12-20 23:11:06",
    "code": "603456"
  },
  {
    "title": "添力CDMO业务 九洲药业与苏州诺华完成股权交割",
    "href": "http://stock.jrj.com.cn/2019/12/20193728564223.shtml",
    "datetime": "2019-12-20 19:37:13",
    "code": "603456"
  },
  {
    "title": "九洲药业：2019年第一次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2019/12/17010028542690.shtml",
    "datetime": "2019-12-17 01:00:11",
    "code": "603456"
  },
  {
    "title": "[九洲药业]合作共赢、信任满满——瑞博制药荣获海和生物“最有价值战略合作伙伴奖”",
    "href": "http://stock.jrj.com.cn/2019/12/09000028558659.shtml",
    "datetime": "2019-12-09 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：第六届董事会第二十次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/11/29235028470981.shtml",
    "datetime": "2019-11-29 23:50:05",
    "code": "603456"
  },
  {
    "title": "九洲药业：关于召开2019年第一次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2019/11/29235028470982.shtml",
    "datetime": "2019-11-29 23:50:05",
    "code": "603456"
  },
  {
    "title": "[九洲药业]共享共赢、创新药定制服务开新花—瑞博制药与贝达药业达成深度战略合作",
    "href": "http://stock.jrj.com.cn/2019/11/19000028420307.shtml",
    "datetime": "2019-11-19 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：关于公司2017年激励计划授予的限制性股票第二期解锁暨上市的公告",
    "href": "http://stock.jrj.com.cn/2019/10/25000128297039.shtml",
    "datetime": "2019-10-25 00:01:21",
    "code": "603456"
  },
  {
    "title": "九洲药业：第六届董事会第十九次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/10/25000128297038.shtml",
    "datetime": "2019-10-25 00:01:20",
    "code": "603456"
  },
  {
    "title": "九洲药业：2019年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/10/25000028296910.shtml",
    "datetime": "2019-10-25 00:00:21",
    "code": "603456"
  },
  {
    "title": "[九洲药业]第一届创新药药物研究(暨绿色制药技术)国际高峰论坛在杭州开幕",
    "href": "http://stock.jrj.com.cn/2019/10/25000028339012.shtml",
    "datetime": "2019-10-25 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：2019年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/10/24205028296135.shtml",
    "datetime": "2019-10-24 20:50:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]九洲药业荣获“2019中国化学制药行业优秀企业和优秀产品品牌”三大奖项",
    "href": "http://stock.jrj.com.cn/2019/10/12000028240827.shtml",
    "datetime": "2019-10-12 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：全资子公司拟收购两家美国公司 提升北美地区服务能力",
    "href": "http://stock.jrj.com.cn/2019/09/10163928116588.shtml",
    "datetime": "2019-09-10 16:39:59",
    "code": "603456"
  },
  {
    "title": "5日公司新闻聚焦：九洲药业拟收购苏州诺华 金字火腿系列产品提价",
    "href": "http://stock.jrj.com.cn/2019/09/05092528092676.shtml",
    "datetime": "2019-09-05 09:25:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]九洲药业收购苏州诺华,赋能创新药定制业务占领新高地",
    "href": "http://stock.jrj.com.cn/2019/09/05000028095312.shtml",
    "datetime": "2019-09-05 00:00:00",
    "code": "603456"
  },
  {
    "title": "持续加码CDMO业务 九洲药业拟7.9亿收购苏州诺华",
    "href": "http://stock.jrj.com.cn/2019/09/04232228090619.shtml",
    "datetime": "2019-09-04 23:22:16",
    "code": "603456"
  },
  {
    "title": "九洲药业收购苏州诺华100%股权",
    "href": "http://stock.jrj.com.cn/2019/09/04214128090409.shtml",
    "datetime": "2019-09-04 21:41:25",
    "code": "603456"
  },
  {
    "title": "九洲药业拟7.9亿元收购苏州诺华 巩固原料药相关业务优势",
    "href": "http://stock.jrj.com.cn/2019/09/04202828090236.shtml",
    "datetime": "2019-09-04 20:28:00",
    "code": "603456"
  },
  {
    "title": "九洲药业拟收购苏州诺华100%股权",
    "href": "http://stock.jrj.com.cn/2019/09/04190628090005.shtml",
    "datetime": "2019-09-04 19:06:43",
    "code": "603456"
  },
  {
    "title": "九洲药业：拟收购苏州诺华100%股权",
    "href": "http://stock.jrj.com.cn/2019/09/04190328090004.shtml",
    "datetime": "2019-09-04 19:03:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：2019年半年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/08/19231027998538.shtml",
    "datetime": "2019-08-19 23:10:17",
    "code": "603456"
  },
  {
    "title": "九洲药业：第六届董事会第十六次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/08/19231027998539.shtml",
    "datetime": "2019-08-19 23:10:17",
    "code": "603456"
  },
  {
    "title": "[九洲药业]省财政厅总预算局局长倪学军一行来九洲药业走访调研",
    "href": "http://stock.jrj.com.cn/2019/07/02000027801559.shtml",
    "datetime": "2019-07-02 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]省经信厅副厅长杜华红一行来九洲药业考察调研",
    "href": "http://stock.jrj.com.cn/2019/05/17000027801564.shtml",
    "datetime": "2019-05-17 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：2018年年度权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2019/05/08010027539328.shtml",
    "datetime": "2019-05-08 01:00:07",
    "code": "603456"
  },
  {
    "title": "九洲药业：年报推10派2元 股权登记5月14日",
    "href": "http://stock.jrj.com.cn/2019/05/07165127537906.shtml",
    "datetime": "2019-05-07 16:51:36",
    "code": "603456"
  },
  {
    "title": "九洲药业2019年第一季度营收下滑16% 净利4343万元 董事长花莉蓉上年末持股3190万股",
    "href": "http://stock.jrj.com.cn/2019/04/23085827463398.shtml",
    "datetime": "2019-04-23 08:58:23",
    "code": "603456"
  },
  {
    "title": "九洲药业：2019年第一季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/04/23080027462780.shtml",
    "datetime": "2019-04-23 08:00:42",
    "code": "603456"
  },
  {
    "title": "[九洲药业]中贝九洲集团第五届职工代表大会暨第五届工会会员代表大会第五次会议顺利召开",
    "href": "http://stock.jrj.com.cn/2019/04/10000027365561.shtml",
    "datetime": "2019-04-10 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]朔州市党政代表团来九洲药业参观考察",
    "href": "http://stock.jrj.com.cn/2019/04/09000027365556.shtml",
    "datetime": "2019-04-09 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：2018年年度股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2019/04/02224027309986.shtml",
    "datetime": "2019-04-02 22:40:03",
    "code": "603456"
  },
  {
    "title": "[九洲药业]临海市委副书记、市长王丹莅临瑞博制药走访调研",
    "href": "http://stock.jrj.com.cn/2019/03/24000027365560.shtml",
    "datetime": "2019-03-24 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]省食药监局副局长邵元昌一行考察海泰医药",
    "href": "http://stock.jrj.com.cn/2019/03/24000027365559.shtml",
    "datetime": "2019-03-24 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业去年净利1.57亿同比增6% 董事长花莉蓉年薪98万元",
    "href": "http://stock.jrj.com.cn/2019/03/12072627152042.shtml",
    "datetime": "2019-03-12 07:26:48",
    "code": "603456"
  },
  {
    "title": "九洲药业扣非净利润增长30%背后：与诺华等国际巨头建立紧密合作关系",
    "href": "http://stock.jrj.com.cn/2019/03/11184627147808.shtml",
    "datetime": "2019-03-11 18:46:38",
    "code": "603456"
  },
  {
    "title": "九洲药业：2018年净利同比增6.46% 拟10派2元",
    "href": "http://stock.jrj.com.cn/2019/03/11172627147511.shtml",
    "datetime": "2019-03-11 17:26:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：2018年净利同比增6% 拟10派2元",
    "href": "http://stock.jrj.com.cn/2019/03/11171427147350.shtml",
    "datetime": "2019-03-11 17:14:10",
    "code": "603456"
  },
  {
    "title": "[九洲药业]情暖新春,九洲药业总经理陈志红博士慰问初一在岗员工",
    "href": "http://stock.jrj.com.cn/2019/02/18000027056455.shtml",
    "datetime": "2019-02-18 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]台州市委副书记、市长张晓强来九洲药业走访调研",
    "href": "http://stock.jrj.com.cn/2019/02/15000027056442.shtml",
    "datetime": "2019-02-15 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]跨越滨江,移师下沙,开启新药定制研发“新时代”——浙江海泰医药新址科研楼启用典礼隆重举行",
    "href": "http://stock.jrj.com.cn/2019/02/15000027056452.shtml",
    "datetime": "2019-02-15 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]加满油、把稳舵、鼓足劲,为实现九洲梦奋勇前进—九洲药业2018年度工作会议顺利召开",
    "href": "http://stock.jrj.com.cn/2019/01/28000027056444.shtml",
    "datetime": "2019-01-28 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]\"手性中国2019\"学术研讨会在深圳召开,九洲药业李原强博士出席会议并颁奖",
    "href": "http://stock.jrj.com.cn/2019/01/16000027056448.shtml",
    "datetime": "2019-01-16 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]九洲药业\"甲磺酸伊马替尼创新合成工艺和产业化\"项目获 2018年浙江省药学会科学技术奖三等奖",
    "href": "http://stock.jrj.com.cn/2018/12/29000026840508.shtml",
    "datetime": "2018-12-29 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：2018年第三次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2018/12/25211026801849.shtml",
    "datetime": "2018-12-25 21:10:03",
    "code": "603456"
  },
  {
    "title": "[九洲药业]绍兴市党政代表团来九洲药业考察",
    "href": "http://stock.jrj.com.cn/2018/12/21000026840507.shtml",
    "datetime": "2018-12-21 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：第六届董事会第十二次会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/12/03232125442555.shtml",
    "datetime": "2018-12-03 23:21:50",
    "code": "603456"
  },
  {
    "title": "九洲药业：关于召开2018年第三次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2018/12/03232125442554.shtml",
    "datetime": "2018-12-03 23:21:49",
    "code": "603456"
  },
  {
    "title": "[九洲药业]省委组织部两新党建处副处长何斌一行莅临九洲药业调研党建工作",
    "href": "http://stock.jrj.com.cn/2018/11/26000026840502.shtml",
    "datetime": "2018-11-26 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：董事拟减持不超100万股",
    "href": "http://stock.jrj.com.cn/2018/11/22181325393012.shtml",
    "datetime": "2018-11-22 18:13:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]参与立功竞赛,助推药都小镇创建—九洲团队在区绿色药都小镇职工技能比武中获得佳绩",
    "href": "http://stock.jrj.com.cn/2018/11/14000026840505.shtml",
    "datetime": "2018-11-14 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]通化市东昌区委书记李长永一行来九洲药业考察交流",
    "href": "http://stock.jrj.com.cn/2018/10/29000028420308.shtml",
    "datetime": "2018-10-29 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：2018年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/10/26005025261218.shtml",
    "datetime": "2018-10-26 00:50:14",
    "code": "603456"
  },
  {
    "title": "九洲药业：第六届董事会第十一次会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/10/26005025261217.shtml",
    "datetime": "2018-10-26 00:50:14",
    "code": "603456"
  },
  {
    "title": "[九洲药业]九洲药业荣获\" 2018中国化学制药行业工业企业综合实力百强\"等多个奖项",
    "href": "http://stock.jrj.com.cn/2018/10/26000025306416.shtml",
    "datetime": "2018-10-26 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]九洲药业新的社会阶层人士联谊会成立",
    "href": "http://stock.jrj.com.cn/2018/10/24000025306413.shtml",
    "datetime": "2018-10-24 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]九洲药业举行2018年度员工教育基金颁发仪式",
    "href": "http://stock.jrj.com.cn/2018/10/23000025306414.shtml",
    "datetime": "2018-10-23 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]九九重阳日,浓浓敬老情—九洲药业走进椒江区福利院",
    "href": "http://stock.jrj.com.cn/2018/10/22000025306415.shtml",
    "datetime": "2018-10-22 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业股东质押1870万股 占比2.32%",
    "href": "http://stock.jrj.com.cn/2018/09/30143625154800.shtml",
    "datetime": "2018-09-30 14:36:00",
    "code": "603456"
  },
  {
    "title": "九洲药业股东质押2160万股 占比2.68%",
    "href": "http://stock.jrj.com.cn/2018/09/30143625154799.shtml",
    "datetime": "2018-09-30 14:36:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]中国化学会手性化学专业委员会完成换届,九洲药业李原强博士当选新一届委员",
    "href": "http://stock.jrj.com.cn/2018/09/29000025167667.shtml",
    "datetime": "2018-09-29 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]九洲药业董事长花莉蓉荣膺\"魅力女浙商·新锐力量奖\"",
    "href": "http://stock.jrj.com.cn/2018/09/25000025167666.shtml",
    "datetime": "2018-09-25 00:00:00",
    "code": "603456"
  },
  {
    "title": "[易事特]易事特成功助力九洲药业向“智慧制药”转型升级!",
    "href": "http://stock.jrj.com.cn/2018/09/20000025119058.shtml",
    "datetime": "2018-09-20 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]九洲药业和海和药物签署战略合作协议",
    "href": "http://stock.jrj.com.cn/2018/09/12000025167669.shtml",
    "datetime": "2018-09-12 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]九洲药业和海和药物签署战略合作协议",
    "href": "http://stock.jrj.com.cn/2018/09/11000025075224.shtml",
    "datetime": "2018-09-11 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]九洲药业科学顾问、中国科学院院士周其林获2018未来科学大奖物质科学奖",
    "href": "http://stock.jrj.com.cn/2018/09/11000025075223.shtml",
    "datetime": "2018-09-11 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：2018年第二次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2018/09/06214025059424.shtml",
    "datetime": "2018-09-06 21:40:03",
    "code": "603456"
  },
  {
    "title": "[九洲药业]台州市委组织部副部长卢红菊来九洲药业调研人才建设工作",
    "href": "http://stock.jrj.com.cn/2018/09/03000025075222.shtml",
    "datetime": "2018-09-03 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：2018年半年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/08/20215024977349.shtml",
    "datetime": "2018-08-20 21:50:15",
    "code": "603456"
  },
  {
    "title": "九洲药业：关于召开2018年第二次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2018/08/20215024977351.shtml",
    "datetime": "2018-08-20 21:50:15",
    "code": "603456"
  },
  {
    "title": "九洲药业：第六届董事会第十次会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/08/20215024977350.shtml",
    "datetime": "2018-08-20 21:50:15",
    "code": "603456"
  },
  {
    "title": "九洲药业：部分高管拟合计增持500万元-1000万元",
    "href": "http://stock.jrj.com.cn/2018/08/13183024945854.shtml",
    "datetime": "2018-08-13 18:30:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]台州市委常委、组织部长吕志良一行莅临九洲药业指导党建工作",
    "href": "http://stock.jrj.com.cn/2018/08/13000025019509.shtml",
    "datetime": "2018-08-13 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]椒江区人才发展大会召开,九洲药业总经理陈志红博士参加会议并发言",
    "href": "http://stock.jrj.com.cn/2018/08/06000028240824.shtml",
    "datetime": "2018-08-06 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：第六届董事会第九次会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/08/02235024897659.shtml",
    "datetime": "2018-08-02 23:50:01",
    "code": "603456"
  },
  {
    "title": "九洲药业：关于公司2017年限制性股票第一次解锁暨上市的公告",
    "href": "http://stock.jrj.com.cn/2018/08/02235024897658.shtml",
    "datetime": "2018-08-02 23:50:01",
    "code": "603456"
  },
  {
    "title": "[互动]九洲药业：子公司环保整改正按计划有序推进",
    "href": "http://stock.jrj.com.cn/2018/07/30154924879325.shtml",
    "datetime": "2018-07-30 15:49:15",
    "code": "603456"
  },
  {
    "title": "九洲药业：与泰格医药在创新药研究领域战略合作",
    "href": "http://stock.jrj.com.cn/hotstock/2018/07/24080024854092.shtml",
    "datetime": "2018-07-24 08:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业与泰格医药签订战略合作协议",
    "href": "http://stock.jrj.com.cn/2018/07/23175124851660.shtml",
    "datetime": "2018-07-23 17:51:52",
    "code": "603456"
  },
  {
    "title": "泰格医药与九洲药业签订战略合作协议",
    "href": "http://stock.jrj.com.cn/2018/07/23175124851659.shtml",
    "datetime": "2018-07-23 17:51:27",
    "code": "603456"
  },
  {
    "title": "泰格医药：与九洲药业签订战略合作协议",
    "href": "http://stock.jrj.com.cn/2018/07/23173024851565.shtml",
    "datetime": "2018-07-23 17:30:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]九洲药业《达卢那韦创新工艺开发》项目获台州市科技进步奖三等奖",
    "href": "http://stock.jrj.com.cn/2018/07/20000025019516.shtml",
    "datetime": "2018-07-20 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]国内首个国家小品种药(短缺药)供应保障联合体成立,九洲药业董事长花莉蓉女士当选药联体副理事长",
    "href": "http://stock.jrj.com.cn/2018/07/20000025167668.shtml",
    "datetime": "2018-07-20 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：实控人拟斥资0.5亿元-1亿元增持",
    "href": "http://stock.jrj.com.cn/hotstock/2018/07/06075924778510.shtml",
    "datetime": "2018-07-06 07:59:54",
    "code": "603456"
  },
  {
    "title": "九洲药业终止重组复牌跌停 实控人拟火线增持",
    "href": "http://stock.jrj.com.cn/2018/07/06031624776597.shtml",
    "datetime": "2018-07-06 03:16:08",
    "code": "603456"
  },
  {
    "title": "7月6日增减持：九洲药业实际控制人拟增持公司5000万元-1亿元",
    "href": "http://stock.jrj.com.cn/2018/07/05182024775354.shtml",
    "datetime": "2018-07-05 18:20:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：实控人拟斥资0.5亿至1亿元增持",
    "href": "http://stock.jrj.com.cn/2018/07/05173524775135.shtml",
    "datetime": "2018-07-05 17:35:00",
    "code": "603456"
  },
  {
    "title": "九洲药业实际控制人拟增持公司5000万元-1亿元",
    "href": "http://stock.jrj.com.cn/2018/07/05172824775119.shtml",
    "datetime": "2018-07-05 17:28:45",
    "code": "603456"
  },
  {
    "title": "九洲药业：董事长、实际控制人拟增持不超过1亿元",
    "href": "http://stock.jrj.com.cn/2018/07/05171724775021.shtml",
    "datetime": "2018-07-05 17:17:16",
    "code": "603456"
  },
  {
    "title": "九洲药业：关于终止重大资产重组暨复牌的公告",
    "href": "http://stock.jrj.com.cn/2018/07/05005024770276.shtml",
    "datetime": "2018-07-05 00:50:09",
    "code": "603456"
  },
  {
    "title": "九洲药业：终止重大资产重组 明日复牌",
    "href": "http://stock.jrj.com.cn/2018/07/04201024769623.shtml",
    "datetime": "2018-07-04 20:10:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]九洲药业总经理陈志红博士参加第九届中国与世界医药企业家高峰会",
    "href": "http://stock.jrj.com.cn/2018/07/02000025019508.shtml",
    "datetime": "2018-07-02 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]李原强博士成为获得以国家企业技术中心平台申请“中国绿卡”的台州第一人",
    "href": "http://stock.jrj.com.cn/2018/07/02000028240828.shtml",
    "datetime": "2018-07-02 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]九洲药业入围\" 2017年度中国制药工业百强\"榜",
    "href": "http://stock.jrj.com.cn/2018/06/26000025019504.shtml",
    "datetime": "2018-06-26 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]九洲药业荣登\" 2018年医药国际化百强企业\"榜",
    "href": "http://stock.jrj.com.cn/2018/06/25000025019515.shtml",
    "datetime": "2018-06-25 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]九洲药业常务副总蒋祖林荣获\"台州市五一劳动奖章\"称号",
    "href": "http://stock.jrj.com.cn/2018/06/25000025019503.shtml",
    "datetime": "2018-06-25 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业子公司江苏瑞科临时停产整顿",
    "href": "http://stock.jrj.com.cn/2018/06/08190224656864.shtml",
    "datetime": "2018-06-08 19:02:46",
    "code": "603456"
  },
  {
    "title": "九洲药业：子公司临时停产",
    "href": "http://stock.jrj.com.cn/2018/06/08184024656747.shtml",
    "datetime": "2018-06-08 18:40:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：筹划收购北京绿竹生物",
    "href": "http://stock.jrj.com.cn/2018/06/05184024640456.shtml",
    "datetime": "2018-06-05 18:40:00",
    "code": "603456"
  },
  {
    "title": "九洲药业筹划重大资产重组事项 6日起继续停牌",
    "href": "http://stock.jrj.com.cn/2018/06/05183224640436.shtml",
    "datetime": "2018-06-05 18:32:39",
    "code": "603456"
  },
  {
    "title": "交易提示：九洲药业临时停牌",
    "href": "http://stock.jrj.com.cn/2018/06/05092024637796.shtml",
    "datetime": "2018-06-05 09:20:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]区人大常委会主任王国平来九洲调研党建工作",
    "href": "http://stock.jrj.com.cn/2018/06/04000025019511.shtml",
    "datetime": "2018-06-04 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]九洲药业加盟中国医药创新促进会",
    "href": "http://stock.jrj.com.cn/2018/05/28000025019519.shtml",
    "datetime": "2018-05-28 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]台州市人大常委会副主任陈祥荣来瑞博制药考察环保工作",
    "href": "http://stock.jrj.com.cn/2018/05/21000025019510.shtml",
    "datetime": "2018-05-21 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]国家外汇管理局台州市中心支局局长肖宗富走访调研九洲",
    "href": "http://stock.jrj.com.cn/2018/05/21000025019512.shtml",
    "datetime": "2018-05-21 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：拟在欧洲设立子公司",
    "href": "http://stock.jrj.com.cn/hotstock/2018/05/17075924551548.shtml",
    "datetime": "2018-05-17 07:59:58",
    "code": "603456"
  },
  {
    "title": "九洲药业：欧洲设立子公司",
    "href": "http://stock.jrj.com.cn/2018/05/16163024548839.shtml",
    "datetime": "2018-05-16 16:30:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]建功新时代,绽放新风采——九洲药业董事长花莉蓉荣膺\"杰出创业女性\"",
    "href": "http://stock.jrj.com.cn/2018/05/14000025019507.shtml",
    "datetime": "2018-05-14 00:00:00",
    "code": "603456"
  },
  {
    "title": "医药股早盘再度走强 九洲药业涨停",
    "href": "http://stock.jrj.com.cn/2018/05/11100024525800.shtml",
    "datetime": "2018-05-11 10:00:00",
    "code": "603456"
  },
  {
    "title": "高送转填权概念再爆发 九洲药业等多股涨停",
    "href": "http://stock.jrj.com.cn/2018/05/10110024520453.shtml",
    "datetime": "2018-05-10 11:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]台州市委组织部副部长项凤日一行莅临九洲调研党建工作",
    "href": "http://stock.jrj.com.cn/2018/04/28000025019506.shtml",
    "datetime": "2018-04-28 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：2018年第一季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/04/26171024457462.shtml",
    "datetime": "2018-04-26 17:10:09",
    "code": "603456"
  },
  {
    "title": "[九洲药业]九洲药业降糖药格列齐特创新合成工艺项目获2017年度浙江省科学技术进步奖三等奖",
    "href": "http://stock.jrj.com.cn/2018/04/23000025019513.shtml",
    "datetime": "2018-04-23 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：关于召开2018年第一次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2018/04/21000324425610.shtml",
    "datetime": "2018-04-21 00:03:31",
    "code": "603456"
  },
  {
    "title": "九洲药业：第六届董事会第五次会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/04/20001024419137.shtml",
    "datetime": "2018-04-20 00:10:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]九洲药业在全市人才发展大会上捧回多项荣誉",
    "href": "http://stock.jrj.com.cn/2018/04/16000025019490.shtml",
    "datetime": "2018-04-16 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]九洲药业总经理陈志红博士当选药促会研发服务专委会委员",
    "href": "http://stock.jrj.com.cn/2018/04/16000025019499.shtml",
    "datetime": "2018-04-16 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]台州市委书记陈奕君考察瑞博制药,寄语企业实现更高质量的裂变式发展",
    "href": "http://stock.jrj.com.cn/2018/04/08000025019492.shtml",
    "datetime": "2018-04-08 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：2017年年度利润分配及资本公积金转增股本实施公告",
    "href": "http://stock.jrj.com.cn/2018/04/02233024341328.shtml",
    "datetime": "2018-04-02 23:30:04",
    "code": "603456"
  },
  {
    "title": "[九洲药业]台州市委副书记、代市长张晓强来公司考察调研",
    "href": "http://stock.jrj.com.cn/2018/03/28000025019495.shtml",
    "datetime": "2018-03-28 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]凤凰行动·浙商股道行—走进九洲药业",
    "href": "http://stock.jrj.com.cn/2018/03/01000025019496.shtml",
    "datetime": "2018-03-01 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]新春送祝福,慰问暖人心—董事长花莉蓉大年初一慰问在岗员工",
    "href": "http://stock.jrj.com.cn/2018/02/16000025019466.shtml",
    "datetime": "2018-02-16 00:00:00",
    "code": "603456"
  },
  {
    "title": "多家公司披露分红预案 九洲药业拟10转8派2元",
    "href": "http://stock.jrj.com.cn/2018/02/13223024116550.shtml",
    "datetime": "2018-02-13 22:30:32",
    "code": "603456"
  },
  {
    "title": "九洲药业：年报净利增三成 拟10转8派2元",
    "href": "http://stock.jrj.com.cn/2018/02/13192524115898.shtml",
    "datetime": "2018-02-13 19:25:00",
    "code": "603456"
  },
  {
    "title": "回复高送转问询函控股股东承诺不减持 九洲药业涨停",
    "href": "http://stock.jrj.com.cn/2018/01/24095123996676.shtml",
    "datetime": "2018-01-24 09:51:18",
    "code": "603456"
  },
  {
    "title": "交易提示：风神股份、九洲药业临时停牌",
    "href": "http://stock.jrj.com.cn/2018/01/23092523989751.shtml",
    "datetime": "2018-01-23 09:25:00",
    "code": "603456"
  },
  {
    "title": "九洲药业、集友股份因送转分红方案遭交易所问询",
    "href": "http://stock.jrj.com.cn/2018/01/22220023987007.shtml",
    "datetime": "2018-01-22 22:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：收到上交所高送转事项问询函暨公司股票停牌",
    "href": "http://stock.jrj.com.cn/2018/01/22214323986943.shtml",
    "datetime": "2018-01-22 21:43:33",
    "code": "603456"
  },
  {
    "title": "九洲药业1亿元发起设立医药基金",
    "href": "http://stock.jrj.com.cn/2018/01/21201723981081.shtml",
    "datetime": "2018-01-21 20:17:41",
    "code": "603456"
  },
  {
    "title": "公告精选：九洲药业推高送转预案；多家公司年报业绩大幅预增",
    "href": "http://stock.jrj.com.cn/2018/01/21185523980923.shtml",
    "datetime": "2018-01-21 18:55:00",
    "code": "603456"
  },
  {
    "title": "九洲药业控股股东提议年度拟10转8并派现",
    "href": "http://stock.jrj.com.cn/2018/01/21184523980918.shtml",
    "datetime": "2018-01-21 18:45:42",
    "code": "603456"
  },
  {
    "title": "九洲药业年报预增30%-50%",
    "href": "http://stock.jrj.com.cn/2018/01/19172723975505.shtml",
    "datetime": "2018-01-19 17:27:11",
    "code": "603456"
  },
  {
    "title": "[九洲药业]九洲药业N0701项目获2017年浙江省药学会科学技术奖三等奖",
    "href": "http://stock.jrj.com.cn/2018/01/08000025019464.shtml",
    "datetime": "2018-01-08 00:00:00",
    "code": "603456"
  },
  {
    "title": "[九洲药业]区委书记陈挺晨一行来公司走访调研",
    "href": "http://stock.jrj.com.cn/2017/12/25000025019458.shtml",
    "datetime": "2017-12-25 00:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：2017年度业绩预增公告",
    "href": "http://stock.jrj.com.cn/2017/12/04220023739177.shtml",
    "datetime": "2017-12-04 22:00:15",
    "code": "603456"
  },
  {
    "title": "九洲药业：2017年度净利润同比预增30%-50%",
    "href": "http://stock.jrj.com.cn/2017/12/04190623738700.shtml",
    "datetime": "2017-12-04 19:06:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：2017年净利预增30%-50%",
    "href": "http://stock.jrj.com.cn/2017/12/04170523738036.shtml",
    "datetime": "2017-12-04 17:05:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：2017年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2017/12/04170023737969.shtml",
    "datetime": "2017-12-04 17:00:00",
    "code": "603456"
  },
  {
    "title": "九洲药业：2017年度业绩预增30％-50％",
    "href": "http://stock.jrj.com.cn/2017/12/04164923737925.shtml",
    "datetime": "2017-12-04 16:49:18",
    "code": "603456"
  },
  {
    "title": "[九洲药业]关注消防,平安你我——记九洲药业消防演练活动",
    "href": "http://stock.jrj.com.cn/2017/11/10000025019461.shtml",
    "datetime": "2017-11-10 00:00:00",
    "code": "603456"
  }
]